Page last updated: 2024-08-25

tricaprin and Hyperlipoproteinemia Type I

tricaprin has been researched along with Hyperlipoproteinemia Type I in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inadera, H; Kobayashi, J; Mori, S; Ohkubo, Y; Saito, Y; Shirai, K; Yoshida, S1

Other Studies

1 other study(ies) available for tricaprin and Hyperlipoproteinemia Type I

ArticleYear
Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.
    Metabolism: clinical and experimental, 1992, Volume: 41, Issue:11

    Topics: Adolescent; Carbon Radioisotopes; Chylomicrons; Dietary Fats; Excipients; Fatty Acids; Female; Heparin; Humans; Hydrolysis; Hyperlipoproteinemia Type I; Injections; Lipase; Lipids; Lipoprotein Lipase; Lipoproteins, VLDL; Liver; Octoxynol; Polyethylene Glycols; Triglycerides; Triolein

1992